Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders.

Products, services, technology

Dipraglurant (mGlu5 NAM) : PD-LID & Blepharospasm
ADX71149 (mGlu2 PAM) : Epilepsy
GABAB PAM :  Addiction & CMT1A
mGlu7 NAM : PTSD
mGlu2 NAM for Mild neurocognitive disorders

M4 PAM : Schizophrenia / psychosis
mGlu4 PAM : Parkinson’s disease
mGlu3 PAM : Neurodegenerative disorders

Location

Chemin des Mines 9, 1202 Geneva, Switzerland

Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    2002
  • Number of employees in Switzerland
    20-49
Key business